Every serving. No expiration date. Page 2 of 6.
In trials, 24% met treatment-stopping criteria versus none on placebo; 19% stayed controlled 24 weeks after stopping all therapy.
In an ongoing trial, nearly three-quarters had not needed the usual treatments after a median of more than two years.
Native plants now shelter fish, pollinators and nesting birds in the middle of the city.
The long pattern—not one day's reading—may help clinicians spot who needs earlier attention.
The estimated air-quality gain closely tracked an 11% drop in vehicles entering the zone.
NASA's newly launched space telescope has cleared an early commissioning test with more optical precision than its requirement demanded.
London's new tunnel intercepted most of the storm-overflow volume its designers modeled for 2025.
Six hospitals changed everyday anesthesia practice, lowering estimated emissions and anesthetic spending without worsening tracked outcomes.
A brief tissue bridge moved helpful algae within three days—and recovery continued after the corals were separated.
The instant discount is reaching first-time electric-car buyers at the dealership.
A new alliance is coordinating five years of targeted recovery funding.
The study will test whether clearing amyloid, then adding a second mechanism, can delay inherited Alzheimer's.
Reported malaria deaths fell from 3,259 in 2011 to 52 in 2025.
A randomized trial found continuous glucose monitoring added about five hours a day in the target range—even without insulin.
An EMA committee recommended a once-daily oral RAS inhibitor for eligible adults with metastatic pancreatic cancer.
Eight complete responses. Twelve patients.
Forty-four, from the brink.
The future changed 2.2 million times.
A pipe budget can become a heat pump.
A 32-person study found less injury and fewer symptoms—but it is still early.
A school challenge has engaged 3,500+ young people in 23 countries to redesign everyday plastic use.
Post-harvest pond water is getting a second job on farms and wetlands.
A monitor improved when patients could explain what its sensors got wrong.
In the OPTIMA extension, adults who stayed on Pasatru had no new lesions detected between weeks 56 and 84; the placebo group had nine.